Fushine keeps pace with the forefront of the pharmaceutical industry, leveraging its integrated product value chain to develop new intermediates and APIs. At the same time, we continuously optimize existing production  to reduce costs and enhance competitiveness.

We have successfully developed a new process for triazole-derived tazobactam and expanded downstream into sterile lyophilized tazobactam sodium APIs, strengthening our core product portfolio. In collaboration with the research team led by Academician Chen Fener of Jiangxi Normal University, we are also advancing innovative asymmetric synthesis technologies for key carbapenem intermediates, further driving efficiency and innovation across the product line.

With deep expertise in halogenation, material separation, and purification technologies, Fushine has built strong capabilities in the production of lithium battery electrolyte additives. By maintaining rigorous control over critical processes and optimizing equipment design and operation, we accelerate production capacity while significantly reducing costs. At the same time, we are expanding into a wide range of advanced electrolyte materials — including LiFSI, DTD, and LiBOB — to build a one-stop electrolyte materials platform. Looking ahead, we will continue to invest in R&D and adopt cutting-edge technologies to enhance product performance, drive innovation, and contribute to the sustainable growth of the new energy industry.

Fushine is the first company in Asia to achieve ton-scale industrial production of filamentous fungal protein. At the same time, we have independently developed a new Fusarium venenatum strain with full intellectual property rights, which has been granted a National Invention Patent. Our project has been officially recognized by the China National Light Industry Council, with its overall technology reaching an internationally advanced level — and its microbial strain development for high-quality protein production achieving a position of global leadership.

In addition, we collaborate with leading academic institutions, including the team of Academician Jian Chen at Jiangnan University, to advance research in process optimization, technological innovation, and downstream product development in microbial protein production.